“The Board of Directors has unanimously chosen Julie Kim to lead Takeda into the next chapter, building on the company’s success under Christophe Weber’s remarkable leadership,” said ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Takeda’s Board of Directors has unanimously appointed Julie Kim, currently the president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Takeda’s current president, CEO and ...

A French court on Monday found French film director Christophe Ruggia guilty of sexually abusing actress Adèle Haenel when she was underage, in one of the first #MeToo cases to emerge from French ...

Takeda Pharmaceutical Company Limited (NYSE ... First of all, we would like to invite our CEO, Christophe Weber to comment. Christophe Weber: Thank you, Chris. Hello, everyone, and thank you ...

And more. 1. Takeda taps Julie Kim to take over for retiring CEO Christophe Weber Takeda has named Julie Kim, currently the company’s U.S. president, to succeed Christophe Weber as its next CEO ...

We would like to share some important news with you. After years of bringing you the latest insights, analysis and innovation news from the pharma industries, we have made the difficult decision to ...

Koichi Mamegano, an analyst from Bank of America Securities, maintained the Buy rating on Takeda Pharmaceutical Co (TKPHF – Research Report). The associated price target is Yen4,800.00.